Evidence map›Paper›PMID 39795461›Full record

ArticlePolymers2024

Optimization of the Heterogeneous Synthesis Conditions for Cellulose Tosylation and Synthesis of a Propargylamine Cellulosic Derivative.

Marcos V Ferreira, Poliana Ricci, Henrique A Sobreira, Anizio M Faria, Rodrigo B Panatieri, Brent S Sumerlin, Rosana M N Assunção

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcos V FerreiraInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, Brazil.ORCID 0000-0001-7263-6444
Poliana RicciInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, Brazil.
Henrique A SobreiraInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, Brazil.ORCID 0009-0007-2387-3970
Anizio M FariaInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, Brazil.ORCID 0000-0001-6915-8963
Rodrigo B PanatieriInstitute of Exact and Natural Sciences, Federal University of Uberlândia, Ituiutaba 38304-402, Brazil.
Brent S SumerlinGeorge & Josephine Butler Polymer Research Laboratory, Department of Chemistry, University of Florida, Gainesville, FL 32608, USA.ORCID 0000-0001-5749-5444
Rosana M N AssunçãoInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, Brazil.

Funding

Console upgrade for microimaging and solid state NMR spectroscopy at 600 MHzS10RR031637 · NCRR · UNIVERSITY OF FLORIDA · PI LONG, JOANNA R · 2011 to 2011
$450k
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 1687830Financiadora de Estudos e Projetos INFR13 01.13.0371.00National Science Foundation Proposal P020225NCRR NIH HHS S10 RR031637
6 · The paper itself

Abstract

Cellulose tosylate (MCC-Tos) is a key derivative for surface modification and a crucial precursor for cellulose compatibilization in click reactions, enabling its functionalization for advanced applications. Replacing tosyl groups with alkyne groups broadens cellulose's potential in biocompatible reactions, such as thiol-yne click chemistry and protein/enzyme immobilization. To achieve this, we optimized the heterogeneous synthesis of MCC-Tos using a Doehlert matrix statistical design, evaluating the influence and interaction of the reaction conditions. The optimized conditions-144 h reaction time, 10:1 molar ratio, and 30 °C-yielded a degree of substitution for tosyl groups (DS

Indexed as

alkyne functionalizationaminopropargyl cellulosecellulose tosylationDoehlert matrix statistical designinfrared spectroscopy

Identifiers

PMID39795461
PMCPMC11722636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.